“Clinical data has shown that there is a significant benefit to using foam dressings, especially those with additional technology such as silicone or antimicrobial properties.”
Vancouver, BC (PRWEB) January 29, 2015
According to a recent report by iData Research (http://www.idataresearch.com), the foam dressing segment is the largest contributor to the moist dressing wound management market. The segment for foam dressings is expected to continue to show strong growth, exceeding a value of USD $330 million by 2019.
“Clinical data has shown that there is a significant benefit to using foam dressings, especially those with additional technology such as silicone or antimicrobial properties,” explains Dr. Kamran Zamanian, CEO of iData. “From a business perspective, foam dressing companies like Medline and Mölnlycke posted strong revenue growth in 2013, primarily from their foam dressing sales.”
Other key findings from the 2014 edition of the iData Research report entitled U.S. Market for Wound and Tissue Management:
As the numbers of competitors increase, and products within a dressing category become increasingly similar, several segments within the overall market for moist dressings will be commoditized. This trend may be offset by competitors bundling their products with ancillary services or other products.
Pressure Ulcer Prevention
A pressure ulcer detected in its early stages can benefit from the application of an advanced dressing. Foam dressings are especially effective prophylaxis in preventing pressure ulcers from worsening. The market for moist wound dressings that are proven to reduce wound healing time will see growth. Additionally, dressings that provide mechanical barriers against incontinence, friction, shear and pressure are increasingly being used.
Successful Wound Management Market Competitor Strategies
Mölnlycke remains the strongest player in this market with their Mepilex® line of foam dressings. This company is posting strong growth year-over-year as a result of a broader scope of use. They have been looking to expand their line of products to supplement and maintain their growth.
Existing and emerging competitors are realizing that they need to have a diverse portfolio to compete effectively. Some manufacturers are attempting to gain market share by providing products at a low cost, while others are constantly launching products with additional technologies. As a result, prices are expected to remain fairly constant.
For Further Information
More on the foam dressing segment and others in the wound and tissue management market in the U.S. can be found in the 2014 edition report published by iData entitled U.S. Market for Wound and Tissue Management. This report includes segments for wound closure, static and dynamic compression therapy, non-adherent contact layers, hemostats, tissue sealants, anti-adhesion products, and negative pressure wound therapy, as well as advanced, moist, antimicrobial, interactive, and traditional wound dressings.
The global series on the market for wound and tissue management covers 22 countries, including the U.S., Japan, Australia, South Korea, Brazil, China, India and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Register online or email us at info(at)idataresearch.net for a U.S. Market for Wound and Tissue Management report brochure and synopsis.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.